We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Biochip Array Technology Detects Drugs in Oral Fluid

By LabMedica International staff writers
Posted on 09 Aug 2011
Print article
A single multiplex assay detects up to 97 drugs and drug metabolites from an undivided oral fluid sample. Matrix dedicated kits ensure reliable assay performance including good specificity, even at lower drug concentrations.

Randox Laboratories (Crumlin, United Kingdom) biochip array technology offers a diagnostic grade testing solution with dependable and reproducible results. The Biochip arrays provide a rapid turnaround time, which is advantageous for onsite workplace drug testing. In comparison, a four-plate automated enzyme linked immunosorbent assay (ELISA) system requires thirteen times longer to process the same results.

A point of collection biochip analyzer was recently launched by Randox--the “Evidence MultiStat,” which processes multiple results in less than twenty minutes. The Biochip platform is multimatrix; therefore, a number of sample types including oral fluid, whole blood, urine, and postmortem tissue can be run on the system. The Randox line of Evidence immunoassay analyzers generate quality control data automatically with every run, ensuring that each test has been carried out successfully.

Randox biochip arrays meet the limit of detection requirements for both the European Workplace Drug Testing Society (EWDT) guidelines for oral fluid testing (2010) and the Australian and New Zealand procedures for specimen collection and the detection and quantification of drugs in oral fluid AS 4760-2006 (2006).

Testing of oral fluid specimens is becoming increasingly popular in the workplace, prisons, and in drug rehabilitation clinics. With a number of benefits to be gained from onsite testing, oral fluid will continue to be put into practice for drugs of abuse screening. As the prevalence of designer drugs and new variations of drugs enter the market, workplace drug testing is set to increase in a bid to detect and deter use. Oral fluid testing is also used as an aid in clinical diagnosis.

Related Links:
Randox Laboratories
European Workplace Drug Testing Society


New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Unit-Dose Packaging solution
HLX
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.